Raise Ebitda/earnings and target price to Rs 27,500; upgrade to Buy

SRCM’s Standalone EBITDA at Rs 9.9 bn (+17% y-o-y, +41% q-o-q) came in 10%/ 20% above our forecast/ Bloomberg consensus estimate, driven by higher volume (+14% y-o-y vs our estimate of +12% y-o-y) and 1% higher blended realisations at Rs 231/bag (vs estimate of Rs 229/bag). Overall per unit costs at Rs 3,114 (-9% y-o-y, -6% q-o-q) were also 2% below estimates. With higher realisation and lower opex, blended Ebitda at Rs 1,513/t (+3% y-o-y, +6% q-q) was 8% above estimate of Rs 1,403/t.

Advertisement

Rural and semi urban housing demand remains strong while infra demand has picked up. We expect demand recovery to accelerate further post festive period. We increase our FY21F/22F/23F cement volume assumptions by 14%/11%/8% and now assume 3% y-y growth in FY21F, followed by 17%/12% y-y growth in FY22-23F. We expect higher realisations to offset cost inflation and record-high Ebitda margins to sustain.

New capacities to drive above industry growth
SRCM has been gaining market share driven by ramp-up of newer capacities. Compared to ~6-12% y-o-y decline for large cap peers over past 12 months, SRCM’s volumes were up 1% y-o-y despite COVID-19 lockdowns. Now, with the commissioning of new 6mt capacity by Dec-20, we expect further market share gains for SRCM.

Recently announced clinker line-3 at Raipur should provide further headroom for growth in fast-growing East India. Further, management highlighted plans to increase grinding capacity from ~40mt to ~57mt over next three years and subsequently to ~80mt over the next 6-7 years.

Raise Ebitda/earnings and target price to Rs 27,500; upgrade to Buy

Driven by higher cement volumes and lower costs, we raise our FY21F/22F/23F core Ebitda by 16%/ 12%/9%, while earnings increase by sharp 36% in FY21F due to lower depreciation and by 13-15% for FY22-23F. We now expect 35% y-o-y EPS growth in FY21F followed by 20%/26% y-o-y growth in FY22-23F, for a 27% FY20-23F EPS CAGR. With above-industry growth rates and profitability, we now value SRCM on 17x Dec-22F EV/Ebitda (earlier 16x Sep-22F EV/Ebitda).

Driven by our Ebitda/multiple increases and roll-forward of valuations, we raise our TP to Rs 27,500 (from Rs 22,000), implying 17% upside. With an improved outlook and recent underperformance vs peers, we upgrade SRCM to Buy (from Neutral). The stock currently trades at 17.6x FY22F EV/Ebitda.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.





Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here